Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Shinkai

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Brain Research|March 6, 1995
Substance P markedly ameliorates scopolamine-induced impairment of spontaneous alternation performance in the mouseM Ukai, N Shinkai, K Ohashi, et al.
Behavioural Brain Research|February 1, 1997
Effects of the kappa-opioid dynorphin A(1-13) on learning and memory in miceM Ukai, J Itoh, T Kobayashi, et al.
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|August 1, 1971
Hemoglobin Tochigi disease, a new unstable hemoglobin hemolytic anemia found in a Japanese familyK Yamada, N Shinkai, S Nakazawa, et al.
General Pharmacology|September 1, 1997
Effects of Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog, on elevated plus-maze learning and spontaneous alternation performance in miceM Ukai, J Monma, N Shinkai, et al.
European Journal of Pharmacology|February 14, 1995
Dynorphin A-(1-13) potently improves scopolamine-induced impairment of passive avoidance response in miceM Ukai, T Kobayashi, N Shinkai, et al.
European Journal of Pharmacology|December 20, 1995
Attenuation of memory with Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog with high affinity for mu-opioid receptorsM Ukai, T Kobayashi, K Mori, et al.
American Journal of Obstetrics and Gynecology|February 1, 1987
Nonsurgical therapy to preserve oviduct function in patients with tubal pregnanciesK Ichinoe, N Wake, N Shinkai, et al.
Nihon Sanka Fujinka Gakkai Zasshi|February 1, 1991
[Changes in serum levels of gynecological tumor markers throughout the period from early gestation to puerperium]T Sugawara, T Tanaka, H Sato, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 29, 2017
Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon-based therapyN Chuaypen, N Posuwan, S Chittmittraprap, et al.
Placenta|May 1, 1987
The propensity to malignancy of dispermic heterozygous molesN Wake, T Fujino, S Hoshi, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Brain Research|March 6, 1995
Substance P markedly ameliorates scopolamine-induced impairment of spontaneous alternation performance in the mouseM Ukai, N Shinkai, K Ohashi, et al.
Behavioural Brain Research|February 1, 1997
Effects of the kappa-opioid dynorphin A(1-13) on learning and memory in miceM Ukai, J Itoh, T Kobayashi, et al.
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|August 1, 1971
Hemoglobin Tochigi disease, a new unstable hemoglobin hemolytic anemia found in a Japanese familyK Yamada, N Shinkai, S Nakazawa, et al.
General Pharmacology|September 1, 1997
Effects of Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog, on elevated plus-maze learning and spontaneous alternation performance in miceM Ukai, J Monma, N Shinkai, et al.
European Journal of Pharmacology|February 14, 1995
Dynorphin A-(1-13) potently improves scopolamine-induced impairment of passive avoidance response in miceM Ukai, T Kobayashi, N Shinkai, et al.
European Journal of Pharmacology|December 20, 1995
Attenuation of memory with Tyr-D-Arg-Phe-beta-Ala-NH2, a novel dermorphin analog with high affinity for mu-opioid receptorsM Ukai, T Kobayashi, K Mori, et al.
American Journal of Obstetrics and Gynecology|February 1, 1987
Nonsurgical therapy to preserve oviduct function in patients with tubal pregnanciesK Ichinoe, N Wake, N Shinkai, et al.
Nihon Sanka Fujinka Gakkai Zasshi|February 1, 1991
[Changes in serum levels of gynecological tumor markers throughout the period from early gestation to puerperium]T Sugawara, T Tanaka, H Sato, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 29, 2017
Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon-based therapyN Chuaypen, N Posuwan, S Chittmittraprap, et al.
Placenta|May 1, 1987
The propensity to malignancy of dispermic heterozygous molesN Wake, T Fujino, S Hoshi, et al.
Pageof 3